Humanwell Healthcare (group) Co.,ltd. Class ASSE: 600079

"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining Drug Registration Certificate for Phloroglucinol Orally Disintegrating Tablets

Sep 12, 2026 · Issued by Humanwell Healthcare (group) Co.,ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining Drug Registration Certificate for Phloroglucinol Orally Disintegrating Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Humanwell Healthcare (group) Co.,ltd. Class A

"Humanwell Healthcare (Group) Co., Ltd."Announcement on Completion of the Sale of Assets by a Wholly-owned SubsidiarySep 5
"Humanwell Healthcare (Group) Co., Ltd."Announcement on the Initiation of Phase II Clinical Trials for RFUS-949 TabletSep 4
"Humanwell Healthcare (Group) Co., Ltd."Indicative Announcement on Acceptance of Application of the Subsidiary for Drug Marketing AuthorizationSep 1
"Humanwell Healthcare (Group) Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance BriefingAug 27

All Humanwell Healthcare (group) Co.,ltd. Class A news releases